Outbreak of Coronavirus (SARS-CoV-2) Delta variant (B.1.617.2) and Delta Plus (AY. 1) with fungal infections, Mucormycosis: Herbal medicine treatment

This review of literature updates the current outbreak of second wave of coronavirus-2 (SARS-CoV-2) mutant Delta variant (B. 1. 617.2) strain and Delta Plus (AY.1) in India followed by the severe black fungus infections, mucormycosis. The mucormycosis, the black fungus infections have been emerged as an additional threat among those recovering from the viral disease, covid-19. Both coronavirus-2 (SARS-CoV-2) mutant strain, B.1.617.2 (Delta variant) and Delta Plus (AY.1) with black fungus has increased covid-19 hospitalizations and killing people in India. The widely accepted treatment of choice for mucormycosis is Amphotericin B. However, these medicines are already exhausted due to the shortage of supply, found very expensive, and fungal strains are resistant during covid-19 outbreak in India. Therefore, traditional herbal medicines with antifungal properties were used as per Auyverdic guidelines as an alternative therapy for controlling this deadly black fungus, mucormycosis during the outbreak of covid-19. Herbal medicines with antifungal activities are easily available in rural areas, less expensive, and traditional healers are practicing herbal therapy as an age old practice for controlling mucormycosis. Herbal formulations are very common household remedies in the rural parts of India.